---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-035665"
form_type: "8-K"
ticker: "MIRA"
cik: "0001904286"
company_name: "MIRA PHARMACEUTICALS, INC."
filed_at: "2026-07-31T21:00:18+00:00"
generated_at: "2026-07-31T21:02:41.446786+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Mira Pharmaceuticals receives Nasdaq delisting notice for bid price below $1

## Summary
- Received Nasdaq letter on July 27, 2026 for failing minimum bid price of $1 per share.
- Has 180 calendar days, until January 25, 2027, to regain compliance.
- To comply, closing bid must be at least $1 for ten consecutive business days.
- May seek an additional 180-day period if it meets other listing standards.
- Stock continues trading on Nasdaq under MIRA; no immediate delisting.

## SEC filing metadata
- accession: 0001493152-26-035665
- form_type: 8-K
- ticker: MIRA
- cik: 0001904286
- company_name: MIRA PHARMACEUTICALS, INC.
- filed_at: 2026-07-31T21:00:18+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1904286/000149315226035665/0001493152-26-035665-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1904286/000149315226035665/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-035665
- JSON: https://secwatch.observer/filing/0001493152-26-035665.json
- Plain text: https://secwatch.observer/filing/0001493152-26-035665.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.